IT1224222B - USE OF BROMOCRIPTINA IN AUTO-IMMUNE AFFECTIONS - Google Patents

USE OF BROMOCRIPTINA IN AUTO-IMMUNE AFFECTIONS

Info

Publication number
IT1224222B
IT1224222B IT48160/87A IT4816087A IT1224222B IT 1224222 B IT1224222 B IT 1224222B IT 48160/87 A IT48160/87 A IT 48160/87A IT 4816087 A IT4816087 A IT 4816087A IT 1224222 B IT1224222 B IT 1224222B
Authority
IT
Italy
Prior art keywords
bromocriptina
affections
immune
auto
immune affections
Prior art date
Application number
IT48160/87A
Other languages
Italian (it)
Other versions
IT8748160A0 (en
Inventor
Douglas Larson
Peter Hiestand
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8748160A0 publication Critical patent/IT8748160A0/en
Application granted granted Critical
Publication of IT1224222B publication Critical patent/IT1224222B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT48160/87A 1986-07-14 1987-07-10 USE OF BROMOCRIPTINA IN AUTO-IMMUNE AFFECTIONS IT1224222B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88511086A 1986-07-14 1986-07-14

Publications (2)

Publication Number Publication Date
IT8748160A0 IT8748160A0 (en) 1987-07-10
IT1224222B true IT1224222B (en) 1990-09-26

Family

ID=25386156

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48160/87A IT1224222B (en) 1986-07-14 1987-07-10 USE OF BROMOCRIPTINA IN AUTO-IMMUNE AFFECTIONS

Country Status (13)

Country Link
JP (1) JPS6323817A (en)
KR (1) KR880001292A (en)
AU (1) AU602154B2 (en)
CH (1) CH672987A5 (en)
DE (1) DE3722383A1 (en)
DK (1) DK363887A (en)
FR (1) FR2601245A1 (en)
GB (1) GB2192541B (en)
IT (1) IT1224222B (en)
NL (1) NL8701631A (en)
PH (1) PH24525A (en)
SE (1) SE8702843L (en)
ZA (1) ZA875145B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814521A1 (en) * 1987-05-07 1988-11-17 Sandoz Ag NEW APPLICATION OF DOPAMINE RECEPTOR AGONISTS
EP0327040A3 (en) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Use of dopamine and/or dopamine agonists to prepare a medicine for the treatment of the digestive tract
US5716933A (en) * 1988-05-10 1998-02-10 Louisiana State University And Agricultural And Mechanical College Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US5830895A (en) * 1988-05-10 1998-11-03 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for the determination and adjustment of prolactin daily rhythms
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
WO1993012793A1 (en) * 1991-12-23 1993-07-08 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College A therapeutic process for the treatment of the pathologies of type ii diabetes
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5626860A (en) * 1995-06-07 1997-05-06 The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US5714519A (en) * 1995-06-07 1998-02-03 Ergo Science Incorporated Method for regulating glucose metabolism
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
PT2091537E (en) 2006-11-23 2013-08-29 Sinoxa Pharma Gmbh Pharmaceutical compositions for the treatment of capillary arteriopathy
DK3445362T3 (en) * 2016-04-20 2021-10-11 Veroscience Llc Composition and method of treatment of metabolic diseases
EP4233913A3 (en) 2017-10-18 2023-10-18 VeroScience LLC Improved bromocriptine formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (en) * 1968-05-31 1971-05-15 Sandoz Ag Process for the preparation of 2-bromo-a-ergocryptine
CH666406A5 (en) * 1984-02-29 1988-07-29 Sandoz Ag METHOD FOR PRODUCING microcapsules BROMOKRIPTINMESYLAT AS PHARMACOLOGICAL ACTIVE INCLUDED.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions

Also Published As

Publication number Publication date
CH672987A5 (en) 1990-01-31
ZA875145B (en) 1989-02-22
SE8702843L (en) 1988-01-15
KR880001292A (en) 1988-04-22
IT8748160A0 (en) 1987-07-10
SE8702843D0 (en) 1987-07-13
NL8701631A (en) 1988-02-01
DK363887D0 (en) 1987-07-13
FR2601245A1 (en) 1988-01-15
DE3722383A1 (en) 1988-01-28
GB8716323D0 (en) 1987-08-19
GB2192541B (en) 1990-05-02
JPS6323817A (en) 1988-02-01
AU7558787A (en) 1988-01-21
GB2192541A (en) 1988-01-20
DK363887A (en) 1988-01-15
PH24525A (en) 1990-07-18
AU602154B2 (en) 1990-10-04

Similar Documents

Publication Publication Date Title
IT1224222B (en) USE OF BROMOCRIPTINA IN AUTO-IMMUNE AFFECTIONS
DE3790726T1 (en) Cosmetic sample
DK683987A (en) TOPICAL PHARMACEUTICAL PREPARATION FOR USE IN THE FORM OF TAPE
DK237187A (en) PHARMACEUTICAL USE OF T-PA
DK633587A (en) PHARMACOLOGICAL / COSMETIC PREPARATION
DK668487D0 (en) COSMETIC PREPARATION
IT1214611B (en) COMPOUNDS FOR DERMATOLOGICAL COSMETIC USE AND RELATED COMPOSITIONS.
KR880701524A (en) Composition of 1-oxohydrocarbyl-substituted azacyclohexane and use thereof
DK400487D0 (en) TRANSDERMAL PREPARATIONS
NO882650L (en) PREPARATIONS FOR USE IN PERMANENT CHANGE OF HAIR COLOR.
IT1224171B (en) IMPROVEMENTS IN CRYPUMPS
DK465487D0 (en) ANXIOLYTIC PREPARATIONS CONTAINING DIOXOPIPERIDE INGREDIATES
FR2593392B1 (en) COSMETIC COMPOSITION
SE8705060L (en) ANTI-COOLING KIT, ANTI-COOLING PREPARATION AND USE OF IT
DK503386D0 (en) PEPTIME PREPARATIONS
IT1217177B (en) PALMITOIL-FRUTTOSIO-1,6-DIFOSFATO, ITS THERAPEUTIC USE AND RELATED METHODS OF PREPARATION
IT1232167B (en) COSMETIC USE OF 3-INDOLPIRUVIC ACID
IT1231426B (en) PREPARATION OF POLYFLUOROENOLATES
SE456221B (en) BACKGROUND OF RADIATIONS, IN PARTICULAR S SOLARIES
IT1214610B (en) COMPOUND FOR DERMATOLOGICAL COSMETIC USE AND RELATED COMPOSITIONS.
ES1000381Y (en) BIOLECTROMAGNETIC FOOTWEAR FOR THERAPEUTIC AND GENERAL USE
BR6601898U (en) OBJECT OF SPECIFIC USE
BR8707180A (en) COMPOSITION LUBRICANT AND USE
ES553205A0 (en) IMPROVEMENTS IN THE CONSTRUCTION OF AUTOCLAVES
DK170586A (en) COSMETIC PREPARATION